0.00Open9.95Pre Close0 Volume2 Open Interest10.00Strike Price0.00Turnover172.22%IV10.65%PremiumDec 20, 2024Expiry Date8.03Intrinsic Value100Multiplier16DDays to Expiry1.92Extrinsic Value100Contract SizeAmericanOptions Type0.9656Delta0.0117Gamma2.21Leverage Ratio-0.0162Theta0.0041Rho2.14Eff Leverage0.0029Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet